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INTRODUCTION
QT interval, also referred to as the electro-
mechanical time is simple to measure from surface
electrocardiogram (ECG) and reflects the overall
ventricular repolarization status . Prolongation of
QT interval in chronic heart failure (CHF) has been
implicated as a risk factor for developing potentially
life threatening ventricular tachy-arrhythmias such
as and sudden cardiac death
(SCD) . Initially, QT prolongation was thought to be
related purely to ageing process, female gender and
persistent systolic pressure overload . However,
recent advances have implicated autonomic nervous
system hyper-stimulation, non-conducting scar from
myocardial infarction, mutations of genes
controlling cardiac ionic channels involved in
cardiac replolarization, left ventricular hypertrophy
(LVH), obesity and elevated insulin level .All these









interval prolongation in patients with CHF depending
on the aetiological factor of left ventricular
dysfunction (LVD). To date, prognostic survival
studies for heart-rate corrected QT interval (QTc) in
patients with CHF are few; although these patients are
known to have a high risk of SCD . With this in
mind, the present study was aimed at determining the
mortality risk associated with prolonged QTc in
Nigerians with CHF.
Ninety-six consecutive CHF patients seen at the
cardiology units of Departments of Medicine,
University of Ilorin Teaching Hospital, Ilorin and
Obafemi Awolowo University Teaching Hospital
Complex, Ile-Ife, Osun State were recruited between
May 2003 and April 2004 with 90 age and sex-
matched normal controls without clinical evidence of
cardiac diseases. Heart failure was defined as the
presence of at least two major criteria or one major
criterion in conjunction with two minor criteria using
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Prognostic survival studies for heart-rate corrected QT interval in patients with
chronic heart failure are few; although these patients are known to have a high risk of sudden cardiac death.
This study was aimed at determining the mortality risk associated with prolonged QTc in Nigerians with heart
failure.
Ninety-six consecutive patients with heart failure were recruited with 90 age and sex-
matched controls.All the subjects had a 12-lead electrocardiogram at a paper speed of 25mm/sec and a rhythm
strip (lead II) at 50mm/sec. The latter was used to calculate the QTc using the Bazett's formula. Left ventricular
systolic and diastolic functions were assessed using 2D guided M-mode and Doppler echocardiogram
respectively. They were followed-up for six months.
Ninety-one patients and 90 controls completed the study. Five patients were lost to follow-up. The
mean age (51.9±16 years) of the patients was similar to that of the controls (50.3±15) (P = 0.475). Twenty-eight
(30.8%) patients died after 6 months of follow-up against none of the controls. The mean QTc was significantly
longer in the non-survivors (0.494±0.027) than in the survivors (0.462±0.035) (P = 0.0001). The percentage
mortality in patients with prolonged QTc against those with normal QTc was 41% and 14% respectively (P =
0.001). In the stepwise regression analysis, QTc was an independent predictor of mortality (R = 0.412, R =
0.17, P= 0.001).
QTc prolongation is a predictor of mortality in CHF and may be an important adjunct in risk
stratification of patients with heart failure.
Chronic Heart Failure, QTc Prolongation, Mortality
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Patients who had recurrent symptoms or persistent
symptoms of heart failure greater than three months
were eligible to participate. Proper education on the
purpose of the study was given to all the subjects and
informed consent was obtained from each of them.
Approval was obtained from Ethics and Research
Committees of the two hospitals. It was a
longitudinal case control study of QTc on mortality
of patients with CHF.
At presentation, all the subjects had detailed clinical
evaluation and were recruited if they were 18 years
and above, had normal serum potassium, did not
have any central nervous system diseases associated
with QTc prolongation (subarachnoid hemorrhage
and ischemic stroke) and were not on drugs known to
cause QTc lengthening such as amiodarone,
halofantrin, risperidol etc . Subjects who did not
meet above criteria or those with atrial fibrillation
were excluded from the study.
A 12-lead ECG was obtained from each subject
using Schiller Cardiovit-10 and Schiller CS 200
machine at a paper speed of 25mm/sec. A rhythm
strip was taken in lead II at a speed of 50mm/sec. The
latter was used to determine the observed QT (QTo)
and the R-R interval. QTo was measured from the
beginning of the QRS complex to the visual return of
the T-wave to the iso-electric line. QTc was
calculated by applying the Bazett's formula : QTc =
vQTo/R-R. The same cardiologist who was blinded
to the clinical status of the subject read the ECG
tracings. Prolonged QTc was defined as QTc = 0.444
and 0.432 in females and males respectively . LVH
was determined using the established method in the
Negroes . Cardiac arrhythmias were noted and
recorded.
The subjects underwent standard 2-Dimensional,
M-mode and Doppler echocardiographic
examination using Siemen's Sonoline G60S and
Siemen's SX machine. The aims were to obtain
evidence of left ventricular (LV) systolic and/or
diastolic dysfunction and to determine the etiology
of CHF in the patients. Anatomic measurements
were performed according to the recommendation
of the American Society of Echocardiography . LV
systolic dysfunction was defined as ejection fraction
(EF) of < 50%. However, the ratio of early (E) and
late (A) mitral in-flow velocities (E/A), Isovolumic
relaxation time (IVRT), deceleration time (DT) and
pulmonary venous flow (PVF) were used to assess
the LV diastolic function . Normal LV diastolic
function was defined as E/A ratio of 1-1.9, IVRT =
80-110ms and DT of 180-240ms while impaired
relaxation was E/A < 1, IVRT = 120ms and DT of =
240ms. Pseudo-normalization was defined as E/A =
1-1.9, IVRT = 80-110ms, DT = 180-240ms and ratio
of PVF S/D < 1, and restrictive pattern was E/A = 2,








on standard treatment for heart failure including
t i t ra ted doses o f f rusemide , po tass ium
supplementation, digoxin if indicated and
angiotensin converting enzyme inhibitors (ACEI).
The patients and the controls were followed up for six
months. The patients were seen initially after two
weeks of presentation or discharge and subsequently
at monthly interval until the end of six months or
death. Clinical state of the patients, acute
exacerbation of symptoms and re-admissions were
monitored.
The data was analyzed using the SPSS version 11 and
the numerical values were presented as mean ±
standard deviation. Student t-test was used to
compare means of continuous variables while chi-
square test was used for proportions. Test of
correlation was done using the Pearson correlation
method. Predictors of mortality were determined by
the stepwise regression analysis. A statistically
significant association was taken at P< 0.05.
Ninety-six CHF patients were recruited, but 91
patients (51 males and 40 females) completed the
study. Five patients were lost to follow-up. The
patients were compared with 90 (51 males and 39
females) age and sex matched controls.Almost all the
patients (91.2%) were in New York HeartAssociation
(NHYA) Class IV with the remaining patients (8.2%)
being in Class III. Systemic hypertension was the
cause of heart failure in 66 patients (72.5%) while
peripartal cardiomyopathy was responsible for heart
failure in 7 patients (8.8%). Rheumatic heart disease
was seen in 5 patients (5.5%), di la ted
cardiomyopathy in 5 patients (5.5%), alcoholic heart
disease in 2 patients (2.2%), atrial septal defect in 1
patient (1.1%) and myocardial infarction in 1 patient
(1.1%). HIV/AIDS was seen in 1 patient (1.1%),
mitral valve prolapse in 1 patient (1.1%) and
hypertrophic cardiomyopathy in 1 patient (1.1%).
Table 1 shows the characteristics of the study
population. The mean patient age was 51.9±16 years
which is similar to the mean age of the controls
(50.3±15) (P = 0.475). The mean serum sodium was
significantly lower in the patients than in the controls
(P = 0.001). However, serum potassium level was
similar in the two groups (P = 0.08). Renal profile
(urea and creatinine) were significantly higher in the
patients than in the controls (P = 0.01 and 0.006
respectively). The mean QTc was significantly
prolonged in the patients than in the controls (P =
0.0001) and cardiac arrhythmias were more prevalent
in the patients than in the controls (P = 0.0001). The
mean left ventricular ejection fraction (LVEF) was
significantly reduced in the patients compared with
the controls (P = 0.0001). Furthermore, the aortic root
dimension, left atrial dimension, and LV mass index
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Table 2: Comparing the Characteristics of CHF
Survivors and Non-survivors
Variable Survivors Non-survivors P value
Number 63 28
Mean age ±SD (years) 51.5±16.8 52.9±14.7 0.694
Mean DOS ±SD (months) 7.0±3.4 9.2±5.3 0.002*
Mean K ±SD mmol/L 3.96±0.37 3.99±0.49 0.75
Mean Na ±SD mmol/L 139.2±4.1 135.8±3.5 0.001*
Mean Urea ±SD mmol/L 5.5±1.4 7.0±21 0.001*
Mean creatinine ±SD µmol/L 86.3±17.9 106.4±27.2 0.001*
Mean QTc±SD 0.462±0.035 0.494±0.027 0.0001*
Mean LVDd ±SD (mm) 60.4±11.2 66.8±12.8 0.02*
Mean LVDs ±SD (mm) 50.0±11.1 58.4±12.3 0.002*
Mean EF ±SD (%) 41.4±10 31.6±9.9 0.0001*
MeanAOD ±SD 31.4±5.4 34.5±4.8 0.013*
Mean LAD±SD 43.6±7.4 45.4±6.6 0.286
+
+
were higher in the patients than in the controls.
Twenty eight patients died within 6 months of
follow-up against none of the controls.
The characteristics of the CHF survivors and non-
survivors are as presented in Table 2. The duration of
symptom of heart failure was significantly longer in
non-survivors than survivors (P = 0.002). Serum
sodium, urea and creatinine were more deranged in
the non-survivors than in survivors. The mean QTc
was significantly longer in non-survivors
(0.494±0.027) than in the survivors (0.462±0.035) (P
= 0.0001). With 0.444 and 0.432 used as the cut off
value in females and males respectively, the QTc was
prolonged in 59 patients (65%) and normal in 32
patients (35%). LV diastolic dimension, LV systolic
dimension, aortic root and left atrial dimensions
were significantly higher in the non-survivors
compared with survivors. However, LVEF was
lower in non-survivors than in survivors (P =
0.0001).
Comparing patients with prolonged and normal QTc,
the mean age and incidence of LVH were similar
between the two groups (P > 0.05). However, cardiac
arrhythmias were more prevalent in patients with
prolonged QTc than normal QTc (P = 0.001). The
percentage mortality in patients with prolonged QTc
against those with normal QTc was 41% and 14%
respectively (P=0.001) as shown in Table 3.
There was significant correlation of QTc and duration
of symptoms of heart failure (r =0.406, p=0.001), LV
diastolic dimension (r=0.251, p=0.016), LV systolic
dimension (r=0.362, p=0.0001), E/A ratio (r=0.282,
p=0.007), deceleration time (r=-0.321, p=0.003),
LVEF (r=-0.368, p=0.0001).
In the stepwise regression analysis, QTc was an
independent predictor of mortality (r=0.412,
R =0.17, P = 0.0001) in model 1 which contained all
the entered variables. However, LVEF and serum
sodium have additive effect to QTc on mortality in
model 2 and 3 as presented in Table 4. Therefore,
patients who have QTc prolongation, low ejection
fraction and hyponatraemia are likely to die than
other patients.
2
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Table 1:
Key: Na - Serum sodium, K - Serum potassium, LVH - Left ventricular hypertrophy, EF -Ejection fraction,
AOD - Aortic root dimension, LAD- Left atrial dimension, LVMI - Left ventricular mass index,
* - Statistically significant.
Shows Characteristics ofThe Study Population
Characteristics PatientsControl P-value
Number 91 90
Mean age ±SD (years) 51.9±16 50.3±15 0.475
Mean Na ±SD (mmol/L) 134.2±5.4 136.9±3.5 0.001*
Mean K ±SD (mmol/L) 3.9±0.31 4.1±0.4 0.08
Mean Urea ±SD (mmol/L) 6.4±1.4 5.2±1.6 0.01*
Mean Creatinine ±SD (Umol/L) 105±13 66.4±16 0.006*
Mean Heart rate ±SD (beats/min) 94.9±16 80.3±10.5 0.001*
Number with LVH 74 (81.3%) 6 (6.7%) 0.0001*
Mean QTc ±SD 0.472±0.036 0.39±0.032 0.0001*
Number with cardiac arrhythmias 51 (56%) 8 (8.9%) 0.0001*
EF ±SD (%) 38.9±11 72.2±8 0.0001*
AOD ±SD (mm) 32.3±5.4 29.7±3.9 0.0001*
LAD ±SD (mm) 44.1±75 33.2±3.7 0.0001*
LVMI ±SD g/m 196.9±65 104.2±23 0.0001*
Number with diastolic dysfunction 58 (63.7%) 8 (8.9%) 0.0001*





Key: DOS- Duration of symptoms, Na - Serum
sodium, K - Serum potassium, LVDd- Left
ventricular diastolic dimension, LVDs- Left
ventricular systolic dimension, EF- Ejection fraction,
AOD Aortic root dimension, LAD- Left atrial
dimension, LVMI Left ventricular mass index,





1 QTc 0.412 0.17 0.0001*
2 QTc, EF 0.487 0.237 0.007*
3 QTc, EF, Na 0.548 0.301 0.006*
4 Others NS NS NS
Key: EF Ejection fraction, Na Serum sodium, * -
Statistically significant,
NS - Not statistically significant
a Predictors = QTc
b Predictors = QTc, EF
c Predictors = QTc, EF, Na
d Dependant variable = outcome
e Age, sex, New York Heart Association (NYHA),
Left ventricular mass index (LVMI), Diastolic
dysfunction, Duration of symptoms.
This study shows derangement of baseline
b ioc hemi ca l , e l e c t r oca rd iog rap h i c an d
echocardiographic parameters in patients with heart
failure compared with normal controls. Cardiac
remodeling and neuro-hormonal alterations as well
as emerging cardio-renal syndrome in heart failure
may account for these changes.
The mean age of the study population was similar to
findings in other studies in Nigeria among heart
failure patients. Majority of patients recruited
were in New York Heart Association (NYHA) class
IV. This is not surprising because many patients in
developing countries often present late to health care
facilities in the course of their diseases. Poverty,
ignorance and poor access to health facilities may be
responsible for this attitude.
The six-month mortality in the present study was
30.8% with survival rate of 69.2%. This rate is high
but comparable with previous studies in Nigeria.
Isezuo et al reported a 6-month mortality of 22% in
Regression Analysis: Model Summary











adult Nigerians and Gambians with hypertensive
heart failure while Ajuluchukwu et al found
mortality of 31% in 121 patients admitted in Lagos.
These mortality figures are higher compared with
those of Caucasians with similar degree of severity of
left ventricular dysfunction. Vtovec et al found a 6-
month mortality rate of 19% in patients with
advanced heart failure. Population-based studies
have shown that patients of African origin with CHF
have higher mortality rate and risk of progression of
LVD than similarly treated Whites.
Comparing patients who survived with non-
survivors, they differ in serum sodium, renal profile,
left ventricular ejection fraction and QTc as shown in
Table 2. The mean serum sodium was significantly
lower in non-survivors than in survivors. It is an
independent predictor of mortality. This is similar to
findings by Balogun et al and Ajuluchukwu et al in
which hyponatraemia was a predictor of intra-
hospital mortality in CHF. Hyponatraemia is
probably due to inappropriate anti-diuretic hormone
(ADH) secretion, a condition which is common in
heart failure and could be dilutional from fluid
retention. Extreme hyponatraemia is an index of cell
death. The role of impaired renal function in the
outcome of patients with heart failure has been
recognized. This study showed a significantly
higher serum urea and creatinine in the non-survivors
than in the survivors. Impaired renal function occurs
as a result of hypoperfusion of the kidneys and in the
hypertensive, there is an additional risk of
arteriolosclerosis as well as nephrosclerosis.
Echocardiographic parameters were more deranged
in the patients that died than in the survivors. The
mean LVEF is an independent predictor of mortality
in this study. The role of LVEF as a predictor of
mortality in heart failure was clearly shown in the
Framingham Heart study and by Balogun et al .
The results of our study indicate that QTc
prolongation is an adverse prognostic sign in heart








Variable Prolonged QTc Normal Qtc P-value
(N1) (N2)
Number 59 32
Mean age ±SD (years) 53.8±13.7 51.2±18 P>0.05
Number with LVH 49 (83%) 26 (81.3) P> 0.05
Number with cardiac arrhythmias 43 (72%) 8 (25%) 0.0001*
Number of survivors 35 (59%) 28 (87%) 0.001*
Number of Non-Survivors 24 (41%) 4 (13%) 0.001*
Key: LVH Left ventricular hypertrophy
* - Statistically significant.
Comparism of CHF Patients with Prolonged (N1) and normal (N2) Qtc
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Framingham Heart Study, QTc prolongation has
been associated with an increased mortality rate in
large population based studies in patients with
cardiac diseases . Until recently, the prognostic
significance of increased QTc in patients with heart
failure was not clear. Indeed, very few studies have
addressed the prognostic significance of increased
QTc as a function of LVEF. The United Kingdom
Heart Failure Evaluation and Assessment of Risk
Trial (UK-HEART) , enrolled 554 ambulatory
patients with CHF. QTc prolongation was a predictor
of mortality on univariate but not on muitivariate
analysis. A recent study which enrolled 2265 CHF
patients with LVEF of = 40%, found QTc
prolongation to be strongly related to mortality in the
whole group and in subsets on the basis of age and the
level of LV systolic function.
Significant correlation was found between duration
of heart failure, LV diastolic dimension, LV systolic
dimension, LVEF, DT, ratio of early and late mitral
(E/A) filling and QTc.Asmall scale study had shown
correlation between the level of severity of LV
diastolic dysfunction and QT interval prolongation
and dispersion . In this study, correlation between
the indices of diastolic dysfunction (E/A ratio, DT)
may suggest the presence of advanced LVD.
Progressive left ventricular disease eventually leads
to increased myocardial stiffness and a rise in
diastolic pressure. The resultant increase in left
ventricular filling pressure and consequent
subendocardial ischaemia predispose the latter to
conduction depolarization delay and QTc
prolongation.
In conclusion, QTc prolongation in heart failure is
associated with adverse outcome as shown by our
study. It is an independent predictor of mortality.
Though the underlying mechanism of QTc
prolongation is not fully understood, it appears that it
may be a good adjunct in risk stratification of
patients with heart failure. The relatively small
number of patients used in this study is a limitation
and we suggest broad base multi-centre studies
enrolling larger number of patients in order to
establish the prognostic effect of QTc in Nigerians
with CHF.
QTc interval as
a guide to select those patients with congestive
heart failure and reduced left ventricular
systolic function who will benefit from anti-
arrhythmic treatment with dofetilide.
Circulation 2001; 103:1422-1427.
QT dispersion and sudden
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